Analyst consensus rating
Surgery Partners Analyst Rating: none
SGRY is rated none by 11 analysts with a $18.73 target. As of 2026-08-27.
Direct answer
Surgery Partners's consensus rating is none.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.73.
Forecast evidence checked August 27, 2026.
Get free Surgery Partners email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.04
- Average price target
- $18.73
- High price target
- $24.00
- Low price target
- $14.00
- Low target gap
- -0.3%
- Target upside
- +33.4%
- High target gap
- +70.9%
- Target range width
- 71.2%
- Consensus rating
- none
- Analysts
- 11
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Surgery Partners?
Surgery Partners has a verified none consensus. The same dataset has an average price target of $18.73.
How far are Surgery Partners's low and high targets from the recorded price?
The low target implies -0.3%, while the high target implies +70.9%.
How many analysts are included in Surgery Partners's consensus?
The verified consensus includes 11 analysts.
How is Surgery Partners's target upside or downside calculated?
The average target of $18.73 is divided by the recorded price of $14.04, then one is subtracted to produce +33.4%. This does not guarantee a future return.
When was Surgery Partners's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.